Articles: 24.10 19 May 2013

Dymista: first steroid plus antihistamine nasal spray

Dymista is a new nasal spray containing fluticasone and azelastine. Our New products review considers the trial evidence for its efficacy and side-effects and suggests its potential role in the treatment of allergic rhinitis.
Dymista first steroid plus antihistamine nasal spray

More details...

How to manage withdrawal of glucocorticoid therapy

Our series on stopping drugs provides practical advice on why, when and how to withdraw drug therapy. Here the authors discuss the issues arising from discontinuing glucocorticoid therapy.
How to manage withdrawal of glucocorticoid therapy

More details...

Inclusion of NICE guidance into local formularies

Recent guidance from NICE requires that NICE-approved medicines must be automatically included into local formularies.
Inclusion of NICE guidance into local formularies

More details...

Invest to save: provision of a medicines management service

The authors describe an invest-to-save scheme involving three London PCTs with the aim of saving between £5 and £7 for every £1 invested in pharmacists working in practices to make savings on prescribing.
Invest to save provision of a medicines management service

More details...

Long-term aspirin use minimally increases risk of age-related macular degeneration

Regular aspirin use for at least 10 years is significantly associated with an increased risk of late-onset, neovascular- subtype, age-related macular degeneration
Longterm aspirin use minimally increases risk of agerelated macular degeneration

More details...

New from NICE

Technology appraisal. Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying antirheumatic drugs (rapid review of TA234) TA280.
New from NICE

More details...

Psoriasis: current treatment options and recent advanc

Management of psoriasis is based on a stepwise approach that includes a wide variety of treatment options. Our Drug review focusses on key points and recent advances in the management of psoriasis, followed by a review of the prescription data and sources of further information.
Psoriasis …

More details...

Twenty-five years of Prozac: has treatment of depression improved?

It is now 25 years since Prozac (fluoxetine) became available for prescribing and SSRIs as a group took off on their journey to become one of the most prescribed group of medications in primary care.
Twenty-five years of Prozac has treatment of depression improved

More details...

Z drugs: their properties and use in treating insomnia

Steve Chaplin, Sue Wilson and Professor David Nutt provide an overview of the properties of Z drugs and how they compare in the short-term treatment of insomnia.
Z drugs- their properties and use in treating insomnia

More details...

Web design and marketing agency Leamington Spa